---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-000951"
form_type: "8-K"
ticker: "INNV"
cik: "0001834376"
company_name: "InnovAge Holding Corp."
filed_at: "2022-02-09T23:59:59+00:00"
generated_at: "2026-06-27T09:41:21.723152+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# InnovAge Q2 EPS $0.01 (down from $0.08); revenue +11.5% but profit and margins fall on medical normalization

## Summary
- Net income $1.1M vs $9.6M YoY; diluted EPS $0.01 vs $0.08.
- Revenue $175.4M, +11.5% YoY on census growth to ~7,050 (+6%).
- Center-level Contribution Margin $41.4M (-6.1%); margin 23.6% (down 4.4pp) on medical cost normalization and center re-openings.
- Adjusted EBITDA $14.8M vs $22.6M; margin 8.4% vs 14.5%.
- Company addressing audit deficiencies in Sacramento and Colorado; CEO notes COVID, labor pressures.

## SEC filing metadata
- accession: 0001558370-22-000951
- form_type: 8-K
- ticker: INNV
- cik: 0001834376
- company_name: InnovAge Holding Corp.
- filed_at: 2022-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834376/000155837022000951/0001558370-22-000951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834376/000155837022000951/tmb-20220209x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-000951
- JSON: https://secwatch.observer/filing/0001558370-22-000951.json
- Plain text: https://secwatch.observer/filing/0001558370-22-000951.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.